Cresco Labs Inc (OTCMKTS:CRLBF) Given Consensus Recommendation of “Buy” by Brokerages
Cresco Labs Inc (OTCMKTS:CRLBF) has received a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $10.37.
A number of analysts have weighed in on CRLBF shares. Canaccord Genuity restated a “buy” rating and set a $11.50 target price on shares of Cresco Labs in a report on Friday, May 29th. Cantor Fitzgerald upped their target price on Cresco Labs from $8.00 to $9.50 and gave the stock an “overweight” rating in a report on Wednesday, May 27th. Finally, Needham & Company LLC started coverage on Cresco Labs in a report on Friday, June 12th. They set a “hold” rating and a $4.20 target price for the company.
Shares of OTCMKTS CRLBF traded up $0.11 during trading hours on Thursday, reaching $4.12. The stock had a trading volume of 324,364 shares, compared to its average volume of 615,320. The business’s fifty day moving average price is $4.41 and its two-hundred day moving average price is $4.65. Cresco Labs has a 52-week low of $1.94 and a 52-week high of $11.09.
Cresco Labs Inc cultivates, manufactures, and sells medical cannabis and medical cannabis products in the United States. It offers cannabis in flower, vape pens, and various forms of extracts under the cresco and Reserve brands; precisely-dosed and non-combustible products, including tinctures, capsules, salves, sublingual oils, and transdermal patches under the Remedi brand; culinary-backed and cannabis-infused edibles under the Mindy's Artisanal brand; and fruity confections under the Mindy's Kitchen brand.
Further Reading: What causes a yield curve to invert?
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.